| Original Studies |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Administration of Cisplatin-Based Chemotherapy for Advanced Urothelial Carcinoma in the Community
Micro-Abstract: Because the frequency of first-line cisplatin-based chemotherapy administration in patients with advanced urothelial carcinoma is unknown, a retrospective study was conducted. A first-...
|
Guru Sonpavde,
Deidre Watson,
Marcia Tourtellott,
C. Lance Cowey,
Beth Hellerstedt,
Thomas E. Hutson,
Feng Zhan,
Nicholas J. Vogelzang
et al.
|
1-5
|
|
|
|
Association of Rash With Outcomes in a Randomized Phase II Trial Evaluating Cetuximab in Combination With Mitoxantrone Plus Prednisone After Docetaxel for Metastatic Castration-resistant Prostate Cancer
Micro-Abstract: This randomized phase II clinical trial analyzed the efficacy of combining cetuximab with mitoxantrone plus prednisone in men with progressive metastatic castrate-resistant prostate ca...
|
Mark T. Fleming,
Guru Sonpavde,
Michael Kolodziej,
Sanjay Awasthi,
Thomas E. Hutson,
Danko Martincic,
Ashutosh Rastogi,
Steven R. Rousey,
Ralph E. Weinstein,
Matthew D. Galsky,
William R. Berry,
Yunfei Wang,
Kristi A. Boehm,
Lina Asmar,
Mary A. Rauch,
Tomasz M. Beer
et al.
|
6-14
|
|
|
|
Impact of the CKD-EPI Equation for Estimating Renal Function on Eligibility for Cisplatin-based Chemotherapy in Patients With Urothelial Cancer
02 December 2011
Micro-Abstract: Combination cisplatin-based chemotherapy is indicated for patients with advanced bladder cancer, but use is often limited due to renal insufficiency. In this study, we retrospectively ...
|
Che-Kai Tsao,
Erin Moshier,
Sonia M. Seng,
James Godbold,
Steven Grossman,
Jonathan Winston,
William K. Oh,
Matthew D. Galsky
et al.
|
15-20
|
|
|
|
Hormonal Therapy or External-Beam Radiation With Brachytherapy and the Risk of Death From Prostate Cancer in Men With Intermediate Risk Prostate Cancer
02 December 2011
Micro-Abstract: Supplemental androgen suppression therapy may lower the risk of prostate-cancer-specific mortality in men with intermediate-risk prostate cancer who are undergoing brachytherapy. Prosp...
|
Jonathan E. Rosenberg,
Ming-Hui Chen,
Paul L. Nguyen,
Michelle H. Braccioforte,
Brian J. Moran,
Anthony V. D'Amico
et al.
|
21-25
|
|
|
|
Phase I Trial of Everolimus Plus Sorafenib for Patients with Advanced Renal Cell Cancer
14 December 2011
Micro-Abstract: This study evaluated the maximum tolerated dose (MTD) of combining everolimus and sorafenib for potential additive effects to treat metastatic renal cell cancer (mRCC). Patients receiv...
|
Robert J. Amato,
Amber L. Flaherty,
Mika Stepankiw
|
26-31
|
|
|
|
Pathological Outcomes of Men Eligible for Active Surveillance After Undergoing Radical Prostatectomy: Are Results Predictable?
21 November 2011
Micro-Abstract: The increasing incidence of low-risk prostate cancer, associated with a downward migration in clinical staging and grading leads to a critical reflection of 612 patients with prostate ...
|
Turang Ed Behbahani,
Jörg Ellinger,
Daniel Garcia Caratozzolo,
Stefan C. Müller
|
32-36
|
|
|
|
Outcome Assessment of Patients With Metastatic Renal Cell Carcinoma Under Systemic Therapy Using Artificial Neural Networks
07 November 2011
Micro-Abstract: The aim of this study was to evaluate the accuracy of artificial neural networks for outcome prediction in metastatic renal cell carcinoma by using clinical and histopathologic data fr...
|
Alexander Buchner,
Martin Kendlbacher,
Philipp Nuhn,
Cordula Tüllmann,
Nicolas Haseke,
Christian G. Stief,
Michael Staehler
et al.
|
37-42
|
|
| Case Reports |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Initial PSA Oscillations Precede Prolonged Stable Disease in a Patient Treated With a Therapeutic Cancer Vaccine
24 October 2011
|
Joseph W. Kim,
Ravi A. Madan,
James L. Gulley
|
43-46
|
|
|
|
Metastatic Clear Cell Adenocarcinoma of the Urethra in a Male Patient: Report of a Case
07 November 2011
|
Stephen V. Liu,
Alexander M. Truskinovsky,
Arkadiusz Z. Dudek,
Ramesh K. Ramanathan
|
47-49
|
|
|
|
Prolonged Hypocalcemia After Zoledronic Acid in a Patient With Metastatic Prostate Carcinoma: Did Zoledronic Acid Trigger Osteoblastic Activity and Avid Calcium Uptake?
16 January 2012
|
Joon Wee Ho,
Santhanam Sundar
|
50-53
|
|
|
|
Paraganglioma Arising from the Prostate: A Case Report and Review of the Literature
24 October 2011
|
Yue Chen,
Ranlu Liu,
Zhihong Zhang,
Yong Xu
|
54-56
|
|
|
|
Nuclear p53 Expression Is Associated With Allelic Imbalance (TP53) in Glandular Dysplasia and Typical Cystitis Glandularis: A LCM-Based Molecular Analysis
28 November 2011
|
Supriya Srivastava,
Benedict Yan,
Sze Yung Chin,
Tuty Muliana,
Manuel Salto-Tellez,
Ming Teh
et al.
|
57-59
|
|
|
|
Primary Lymphoma of the Kidney: Case Report and Review of Literature
|
Tommaso Brancato,
Rosaria Alvaro,
Gianni Paulis,
Pietro Nupieri,
Roberto D'Ascenzo,
Giuseppe Orsolini
et al.
|
60-62
|
|
|
|
Malignant Small Round Blue Cell Tumor of the Kidney Without EWSR1 Rearrangement: Report of a Case and Review of the Literature
08 December 2011
|
William E. Osai,
Elizabeth G. Demicco,
Lance C. Pagliaro
|
63-65
|
|
| Frontmatter |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Editorial Board
|
|
A4
|
|
|
|
Table of Contents
|
|
A6-A7
|
|
